Mallinckrodt Plc Ordinary Shares Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (28)

Latest Posts

About This Stock More About This Stock
Mallinckrodt Drops As Citron Takes Aim Again
Article By: The Fly
Monday, November 26, 2018 3:52 PM EDT
In afternoon trading, shares of Mallinckrodt have dropped almost 10% to $23.88.
In this article: MNK
Read
Mallinckrodt Selloff On Praxair FDA Approval Seen As Overreaction
Article By: The Fly
Thursday, October 4, 2018 5:20 PM EDT
In afternoon trading, shares of Mallinckrodt have plunged over 18% to $25.43.
In this article: MNK, PX
Read
Mallinckrodt - Chart Of The Day
Article By: Jim Van Meerten
Thursday, August 16, 2018 7:51 PM EDT
Mallinckrodt Plc. develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. Revenue expected to grow 30.20% this year.
In this article: MNK
Read
Mallinckrodt: Acthar, Deteriorating Credit Metrics Are Concerning
Article By: Shock Exchange
Wednesday, February 28, 2018 9:53 AM EDT
MNK produced a Q4 revenue beat, yet revenue still fell 5% Y/Y. Acthar revenue was off 9% Y/Y. This is a cause for concern. Debt/EBITDA rose to 4.8x. It could deteriorate further after the Sucampo deal.
In this article: MNK
Read
Mallinckrodt: Is The Generics Sale In Trouble?
Article By: Shock Exchange
Monday, January 29, 2018 2:08 PM EDT
MNK has been in the market to sell its Specialty Generics unit since Q1 2017. Market chatter implies MNK received disappointing bids. If the unit is not sold it could be a drag on Q4 earnings or hurt MNK's credit metrics.
In this article: MNK Also: SCMP
Read

PARTNER HEADLINES

Latest Tweets for $MNK

No tweets yet!

$MNK

Mallinckrodt - Chart Of The Day
Kurt Benson 8/17/2018 8:35:38 AM

Been waiting for $MNK to get some positive attention.

1 to 1 of 1 comments